NCT04664998View on ClinicalTrials.gov

Alignment of PrEP Use With HIV Risk in Young Women and Men

PHASE4CompletedINTERVENTIONAL
Enrollment

212

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 10, 2023

Study Completion Date

December 10, 2023

Conditions
Pre-Exposure ProphylaxisSexually Transmitted Diseases, BacterialHIV Infections
Interventions
DRUG

Daily oral PrEP

All participants will be offered daily oral PrEP at each visit

DRUG

Daily oral PrEP

All participants will be offered daily oral PrEP at each visit.

Trial Locations (1)

Unknown

Infectious Disease Institute, Kampala

All Listed Sponsors
collaborator

Makerere University

OTHER

collaborator

MU-JHU CARE

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Washington

OTHER

NCT04664998 - Alignment of PrEP Use With HIV Risk in Young Women and Men | Biotech Hunter | Biotech Hunter